de Baat, E. C., van Dalen, E. C., Mulder, R. L., Hudson, M. M., Ehrhardt, M. J., Engels, F. K., Feijen, E. A. M., Grotenhuis, H. B., Leerink, J. M., Kapusta, L., Kaspers, G. J. L., Merkx, R., Mertens, L., Skinner, R., Tissing, W. J. E., de Vathaire, F., Nathan, P. C., Kremer, L. C. M., Mavinkurve-Groothuis, A. M. C., & Armenian, S. (2022). primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet, 6, 885–894. http://access.bl.uk/ark:/81055/vdc_100170091601.0x000009